Boryung Pharmaceutical Invests 24 Billion KRW in U.S. Local Corporation
[Asia Economy Reporter Minji Lee] Boryung Pharmaceutical announced on the 30th that it will invest 24 billion KRW in its local US corporation (Hayan I, L.P.). The investment amount corresponds to 8.5% of its equity capital.
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- Takaichi Says, "I Was Debating Drinking Due to Parliament Schedule"... President Lee Jokes, "Should I Make a Call?"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Boryung Pharmaceutical stated, "This is to secure global investment opportunities and enhance the possibility of expanding business areas through investment in a US fund."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
